通过E2F介导的POLA2上调与巨细胞透和肝细胞癌的不良预后相关

Yao Teng1, Ran Liu2

  • 1Department of Rheumatology and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

概括

在肝细胞癌 (HCC) 中,DNA聚合酶I亚单元2 (POLA2) 过度表达,与生存率差和免疫细胞透相关. POLA2显示出作为早期HCC诊断和预后的新生物标志物的潜力.